These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9613750)

  • 21. [Clinical and electrophysiological features of "cortical tremor"].
    Delval A; Krystkowiak P; Cassim F; Szurhaj W; Charpentier P; Mastain B; Guieu JD; Destée A; Defebvre L
    Rev Neurol (Paris); 2003 May; 159(5 Pt 1):518-27. PubMed ID: 12773897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological observations in hereditary parkinsonism-dementia with Lewy body pathology.
    Caviness JN; Gwinn-Hardy K; Adler CH; Muenter MD
    Mov Disord; 2000 Jan; 15(1):140-5. PubMed ID: 10634254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhythmic cortical myoclonus in a case of HIV-related encephalopathy.
    Canafoglia L; Panzica F; Franceschetti S; Carriero MR; Ciano C; Scaioli V; Chiapparini L; Visani E; Avanzini G
    Mov Disord; 2003 Dec; 18(12):1533-8. PubMed ID: 14673894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of L-dopa on event-related desynchronization in Parkinson's disease.
    Magnani G; Cursi M; Leocani L; Volonté MA; Comi G
    Neurol Sci; 2002 Sep; 23(3):91-7. PubMed ID: 12391492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical Myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential.
    Caviness JN; Kurth M
    Mov Disord; 1997 Nov; 12(6):1046-51. PubMed ID: 9399235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial cortical myoclonic tremor as a unique form of cortical reflex myoclonus.
    Terada K; Ikeda A; Mima T; Kimura M; Nagahama Y; Kamioka Y; Murone I; Kimura J; Shibasaki H
    Mov Disord; 1997 May; 12(3):370-7. PubMed ID: 9159732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jerk-locked averaging: technique and application.
    Barrett G
    J Clin Neurophysiol; 1992 Oct; 9(4):495-508. PubMed ID: 1464676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease.
    Caviness JN; Adler CH; Sabbagh MN; Connor DJ; Hernandez JL; Lagerlund TD
    Mov Disord; 2003 Oct; 18(10):1157-62. PubMed ID: 14534920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: case report.
    Gambarin M; Antonini A; Moretto G; Bovi P; Romito S; Fiaschi A; Tinazzi M
    Mov Disord; 2006 Feb; 21(2):270-3. PubMed ID: 16161148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic medication unrelated myoclonus is less related to tremor in idiopathic Parkinson's disease.
    Sifoglu A; Gunduz A; Kiziltan G; Kiziltan ME
    Neurol Sci; 2017 Apr; 38(4):679-682. PubMed ID: 27990561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Throat clicking as the initial symptom of Parkinson's disease.
    Iyer SS; Morgan JC; Glover AL; Sethi KD
    Mov Disord; 2005 Oct; 20(10):1385-6. PubMed ID: 16001408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortico-cortical coupling in Parkinson's disease and its modulation by therapy.
    Silberstein P; Pogosyan A; Kühn AA; Hotton G; Tisch S; Kupsch A; Dowsey-Limousin P; Hariz MI; Brown P
    Brain; 2005 Jun; 128(Pt 6):1277-91. PubMed ID: 15774503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
    Shoulson I; Oakes D; Fahn S; Lang A; Langston JW; LeWitt P; Olanow CW; Penney JB; Tanner C; Kieburtz K; Rudolph A;
    Ann Neurol; 2002 May; 51(5):604-12. PubMed ID: 12112107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological studies of myoclonus.
    Shibasaki H; Hallett M
    Muscle Nerve; 2005 Feb; 31(2):157-74. PubMed ID: 15547927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: a prospective 12-month paired TMS study.
    Bares M; Kanovský P; Rektor I
    Parkinsonism Relat Disord; 2007 Dec; 13(8):489-94. PubMed ID: 17449315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration.
    Quadri R; Comino I; Scarzella L; Cacioli P; Zanone MM; Pipieri A; Bergamasco B; Chiandussi L
    Funct Neurol; 2000; 15(2):81-6. PubMed ID: 10916719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.